USD 51.55
(9.31%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 127.47 Million USD | 7.79% |
2022 | 118.25 Million USD | 12.63% |
2021 | 104.99 Million USD | 13.8% |
2020 | 92.26 Million USD | 49.48% |
2019 | 61.72 Million USD | 57.67% |
2018 | 39.14 Million USD | 50.41% |
2017 | 26.02 Million USD | 280.9% |
2016 | 6.83 Million USD | 2.34% |
2015 | 6.67 Million USD | 66.22% |
2014 | 4.01 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 128.53 Million USD | 0.83% |
2024 Q3 | 136.98 Million USD | 7.55% |
2024 Q2 | 127.37 Million USD | -0.9% |
2023 Q2 | 130.77 Million USD | 5.38% |
2023 FY | 127.47 Million USD | 7.79% |
2023 Q4 | 127.47 Million USD | -4.04% |
2023 Q3 | 132.84 Million USD | 1.58% |
2023 Q1 | 124.09 Million USD | 4.93% |
2022 Q3 | 114.69 Million USD | -0.41% |
2022 Q1 | 112.95 Million USD | 7.59% |
2022 Q4 | 118.25 Million USD | 3.1% |
2022 FY | 118.25 Million USD | 12.63% |
2022 Q2 | 115.17 Million USD | 1.96% |
2021 Q2 | 89.8 Million USD | 0.87% |
2021 Q4 | 104.99 Million USD | 10.33% |
2021 FY | 104.99 Million USD | 13.8% |
2021 Q3 | 95.16 Million USD | 5.97% |
2021 Q1 | 89.03 Million USD | -3.5% |
2020 FY | 92.26 Million USD | 49.48% |
2020 Q1 | 69.42 Million USD | 12.47% |
2020 Q2 | 82.21 Million USD | 18.42% |
2020 Q3 | 80.42 Million USD | -2.17% |
2020 Q4 | 92.26 Million USD | 14.72% |
2019 Q3 | 53.67 Million USD | 12.33% |
2019 Q2 | 47.78 Million USD | 7.93% |
2019 FY | 61.72 Million USD | 57.67% |
2019 Q4 | 61.72 Million USD | 15.0% |
2019 Q1 | 44.26 Million USD | 13.08% |
2018 Q2 | 35.4 Million USD | 9.35% |
2018 Q3 | 38.61 Million USD | 9.06% |
2018 FY | 39.14 Million USD | 50.41% |
2018 Q1 | 32.38 Million USD | 24.41% |
2018 Q4 | 39.14 Million USD | 1.38% |
2017 Q3 | 18.06 Million USD | 45.56% |
2017 Q2 | 12.41 Million USD | 57.91% |
2017 Q1 | 7.85 Million USD | 15.02% |
2017 FY | 26.02 Million USD | 280.9% |
2017 Q4 | 26.02 Million USD | 44.08% |
2016 Q3 | 7.66 Million USD | -8.78% |
2016 Q1 | 8.15 Million USD | 22.17% |
2016 FY | 6.83 Million USD | 2.34% |
2016 Q4 | 6.83 Million USD | -10.87% |
2016 Q2 | 8.4 Million USD | 3.03% |
2015 Q3 | 6.03 Million USD | -3.87% |
2015 FY | 6.67 Million USD | 66.22% |
2015 Q4 | 6.67 Million USD | 10.69% |
2015 Q2 | 6.27 Million USD | 15.71% |
2015 Q1 | 5.42 Million USD | 35.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 4.01 Million USD | 0.0% |
2014 Q4 | 4.01 Million USD | 47.74% |
2014 Q3 | 2.71 Million USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Biodesix, Inc. | 1.4 Million USD | -9005.357% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -689550.509% |
Castle Biosciences, Inc. | 7.94 Million USD | -1505.074% |
DarioHealth Corp. | 5.06 Million USD | -2418.273% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 66.479% |
Illumina, Inc. | 587 Million USD | 78.284% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -16294.718% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | -520.83% |
23andMe Holding Co. | 12.46 Million USD | -922.663% |
Medpace Holdings, Inc. | 1.00 USD | -12747499900.0% |
NeoGenomics, Inc. | 24.15 Million USD | -427.716% |
Inotiv, Inc. | 56.1 Million USD | -127.22% |
Psychemedics Corporation | 1.00 USD | -12747499900.0% |
Prenetics Global Limited | 3.12 Million USD | -3976.883% |
Precipio, Inc. | 384 Thousand USD | -33096.615% |
RadNet, Inc. | 1.00 USD | -12747499900.0% |
Sotera Health Company | 51.98 Million USD | -145.215% |
Star Equity Holdings, Inc. | 3.42 Million USD | -3627.339% |
Exagen Inc. | 2.87 Million USD | -4340.091% |
Natera, Inc. | 40.75 Million USD | -212.753% |
Aspira Women's Health Inc. | 227 Thousand USD | -56056.388% |
Neogen Corporation | 189.26 Million USD | 32.648% |
Myriad Genetics, Inc. | 20.1 Million USD | -534.204% |
ICON Public Limited Company | 1.00 USD | -12747499900.0% |
Bionano Genomics, Inc. | 22.89 Million USD | -456.83% |
CareDx, Inc | 19.47 Million USD | -554.692% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 32.06 Million USD | -297.577% |
Guardant Health, Inc. | 61.94 Million USD | -105.777% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -11103.934% |
Fulgent Genetics, Inc. | 5.82 Million USD | -2087.661% |
Sera Prognostics, Inc. | - USD | -Infinity% |
OPKO Health, Inc. | 65.69 Million USD | -94.035% |
Personalis, Inc. | 5.66 Million USD | -2151.811% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -38525.628% |
Star Equity Holdings, Inc. | 3.42 Million USD | -3627.339% |
MDxHealth SA | 2.77 Million USD | -4487.082% |
Prenetics Global Limited | 3.12 Million USD | -3976.883% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -4760.143% |
Mainz Biomed B.V. | 613.63 Thousand USD | -20673.648% |
Trinity Biotech plc | 19.93 Million USD | -539.517% |
Neuronetics, Inc. | 8.09 Million USD | -1475.127% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -689550.509% |